在HRAS突变头状细胞癌的免疫学景观

P Economopoulou1, T Rampias2, A Spathis3

  • 1Oncology Unit, 2nd Department of Internal Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Haidari, Greece.

ESMO open
|August 13, 2025
PubMed
概括

头癌中的HRAS突变与免疫细胞透和PD-L1表达的增加有关. 这些发现表明HRAS突变瘤可能对免疫疗法治疗反应良好.